Related Experiment Video
Updated: Mar 11, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Presenting treatment safety data: subjective interpretations of objective information
Sara W Faulks1, Steven R Feldman1
1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Patient understanding of treatment risks, especially with biologic medications for psoriasis, can be skewed by how safety data is presented. Physicians must carefully choose data visualization to ensure accurate patient comprehension and informed treatment decisions.
Area of Science:
- Dermatology
- Medical Education
- Health Psychology
Background:
- Educating patients on treatment risks is crucial but can lead to fear of rare side effects.
- This fear may cause treatment refusal or non-adherence, particularly with biologic medications for psoriasis.
- Subjective patient interpretation of objective safety data presents a significant challenge in clinical practice.
Purpose of the Study:
- To illustrate how graphical presentations of psoriasis safety data influence patient subjective interpretation.
- To highlight the impact of different y-axis formats (truncated, full, inverted) on patient perception of risk.
- To emphasize the need for careful physician judgment in presenting safety information to patients.
Main Methods:
- Analysis of subjective patient interpretations of objective safety data.
- Use of graphical data presentation methods, including varied y-axis scales.
- Qualitative assessment of patient-physician communication regarding treatment risks.
Main Results:
- Graphical presentation of safety data significantly impacts patient perception of risk.
- Different y-axis scales (truncated, full, inverted) lead to distinct patient interpretations.
- Physicians' intended objective information can be subjectively perceived by patients.
Conclusions:
- Patient interpretation of treatment risks is subjective and influenced by data presentation.
- Physicians must exercise careful judgment when presenting safety data, using appropriate graphical formats.
- Optimizing risk communication is essential for informed decision-making, treatment adherence, and patient well-being in psoriasis management.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blind Procedures
Bioequivalence Data: Statistical Interpretation
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Hazard Ratio
For example, in a clinical trial...